Videos Library
HTA in the changing development and regulatory landscape
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR
Overview
- What is driving changes such as conditional market authorisation and adaptive pathways?
- What are the challenges for HTA agencies and their evaluation approaches?
- What are the critical success factors for pharma companies?
Speaker
Anke van Engen
Principal, Consulting Services
QuintilesIMS
Photo
Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.
Sponsor
